Literature DB >> 18367647

Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

Sahoko Matsuoka1, Yuichi Oike, Ichiro Onoyama, Atsushi Iwama, Fumio Arai, Keiyo Takubo, Yoichi Mashimo, Hideyuki Oguro, Eriko Nitta, Keisuke Ito, Kana Miyamoto, Hiroki Yoshiwara, Kentaro Hosokawa, Yuka Nakamura, Yumiko Gomei, Hiroko Iwasaki, Yasuhide Hayashi, Yumi Matsuzaki, Keiko Nakayama, Yasuo Ikeda, Akira Hata, Shigeru Chiba, Keiichi I Nakayama, Toshio Suda.   

Abstract

Common molecular machineries between hematopoietic stem cell (HSC) maintenance and leukemia prevention have been highlighted. The tumor suppressor Fbxw7 (F-box and WD-40 domain protein 7), a subunit of an SCF-type ubiquitin ligase complex, induces the degradation of positive regulators of the cell cycle. We demonstrate that inactivation of Fbxw7 in hematopoietic cells causes premature depletion of HSCs due to active cell cycling and p53-dependent apoptosis. Interestingly, Fbxw7 deletion also confers a selective advantage to cells with suppressed p53 function, eventually leading to development of T-cell acute lymphoblastic leukemia (T-ALL). Thus, Fbxw7 functions as a fail-safe mechanism against both premature HSC loss and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367647      PMCID: PMC2335330          DOI: 10.1101/gad.1621808

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  33 in total

Review 1.  Ubiquitin and ubiquitin-like proteins as multifunctional signals.

Authors:  Rebecca L Welchman; Colin Gordon; R John Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

2.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

3.  Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development.

Authors:  Ryosuke Tsunematsu; Keiko Nakayama; Yuichi Oike; Masaaki Nishiyama; Noriko Ishida; Shigetsugu Hatakeyama; Yasumasa Bessho; Ryoichiro Kageyama; Toshio Suda; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

4.  Identification of the haematopoietic stem cell niche and control of the niche size.

Authors:  Jiwang Zhang; Chao Niu; Ling Ye; Haiyang Huang; Xi He; Wei-Gang Tong; Jason Ross; Jeff Haug; Teri Johnson; Jian Q Feng; Stephen Harris; Leanne M Wiedemann; Yuji Mishina; Linheng Li
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

5.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

6.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

7.  Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein.

Authors:  Michael T Tetzlaff; Wei Yu; Mamie Li; Pumin Zhang; Milton Finegold; Kathleen Mahon; J Wade Harper; Robert J Schwartz; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

8.  Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.

Authors:  Susanna Ekholm-Reed; Charles H Spruck; Olle Sangfelt; Frank van Drogen; Elisabeth Mueller-Holzner; Martin Widschwendter; Anders Zetterberg; Steven I Reed; Susanna Ekholm Reed
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Inactivation of hCDC4 can cause chromosomal instability.

Authors:  Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

10.  hCDC4 gene mutations in endometrial cancer.

Authors:  Charles H Spruck; Heimo Strohmaier; Olle Sangfelt; Hannes M Müller; Michael Hubalek; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter; Steven I Reed
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

View more
  89 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells.

Authors:  Fei Liu; Jae Y Lee; Huijun Wei; Osamu Tanabe; James D Engel; Sean J Morrison; Jun-Lin Guan
Journal:  Blood       Date:  2010-08-17       Impact factor: 22.113

3.  TBK1 regulates prostate cancer dormancy through mTOR inhibition.

Authors:  Jin Koo Kim; Younghun Jung; Jingcheng Wang; Jeena Joseph; Anjali Mishra; Elliott E Hill; Paul H Krebsbach; Kenneth J Pienta; Yusuke Shiozawa; Russell S Taichman
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

Review 4.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

5.  The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.

Authors:  Uta Kossatz; Kai Breuhahn; Benita Wolf; Matthias Hardtke-Wolenski; Ludwig Wilkens; Doris Steinemann; Stephan Singer; Felicitas Brass; Stefan Kubicka; Brigitte Schlegelberger; Peter Schirmacher; Michael P Manns; Jeffrey D Singer; Nisar P Malek
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

Review 6.  Regulation of cancer stem cells by RING finger ubiquitin ligases.

Authors:  Bin Kang; Xiao-Hong Sun
Journal:  Stem Cell Investig       Date:  2014-02-09

7.  MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.

Authors:  Beatriz Aranda-Orgilles; Ricardo Saldaña-Meyer; Eric Wang; Eirini Trompouki; Anne Fassl; Stephanie Lau; Jasper Mullenders; Pedro P Rocha; Ramya Raviram; María Guillamot; María Sánchez-Díaz; Kun Wang; Clarisse Kayembe; Nan Zhang; Leonela Amoasii; Avik Choudhuri; Jane A Skok; Markus Schober; Danny Reinberg; Piotr Sicinski; Heinrich Schrewe; Aristotelis Tsirigos; Leonard I Zon; Iannis Aifantis
Journal:  Cell Stem Cell       Date:  2016-08-25       Impact factor: 24.633

8.  Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.

Authors:  Chen Tian; Guoguang Zheng; Zhipan Cao; Qiao Li; Zhenyu Ju; Jinhong Wang; Weiping Yuan; Tao Cheng
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

9.  Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis.

Authors:  John M Perry; Linheng Li
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

Review 10.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.